Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Testing effectiveness (Phase 2)Study completedNCT00153010
What this trial is testing

An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 430
Large-scale testing (Phase 3)Study completedNCT04994483
What this trial is testing

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 804
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Large-scale testing (Phase 3)Study completedNCT01955161
What this trial is testing

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 933
Testing effectiveness (Phase 2)Looking for participantsNCT06995573
What this trial is testing

Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
NSC-Therapeutics 90
Testing effectiveness (Phase 2)Ended earlyNCT06721156
What this trial is testing

Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Who this might be right for
Alzheimer DiseaseDementia
Merck Sharp & Dohme LLC 369
Early research (Phase 1)Study completedNCT00766363
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System Diseases
FORUM Pharmaceuticals Inc 49
Large-scale testing (Phase 3)UnknownNCT00217763
What this trial is testing

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Bellus Health Inc. - a GSK company 930
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Not applicableUnknownNCT02227953
What this trial is testing

A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease

Who this might be right for
Alzheimer's Disease
Samsung Medical Center 20
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)UnknownNCT03865017
What this trial is testing

A Safety and Tolerability Study of GB301

Who this might be right for
Alzheimer Disease
VTBIO Co. LTD 20
Large-scale testing (Phase 3)Study completedNCT00829374
What this trial is testing

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 1,003
Testing effectiveness (Phase 2)Ended earlyNCT01238991
What this trial is testing

Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 53
Early research (Phase 1)Study completedNCT01485302
What this trial is testing

Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's Patients

Who this might be right for
Alzheimer's Disease
Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT03867253
What this trial is testing

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Oryzon Genomics S.A. 24
Testing effectiveness (Phase 2)Study completedNCT01018875
What this trial is testing

Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 242
Not applicableUnknownNCT06008639
What this trial is testing

Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Danyang Huichuang Medical Equipment Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT03038035
What this trial is testing

The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study

Who this might be right for
Alzheimer Disease
National University Hospital, Singapore 150
Next Page